A nurse receives report on four clients. The nurse should first collect data about the client who has which of the following?

A. Name and medical record number: This information is unique to each individual and is used to accurately identify patients in healthcare settings, including newborns.
B. Birth date and mother's name: While important for identification, this information alone may not be sufficient to accurately identify a newborn, especially in situations where there may be multiple newborns with similar birth dates or mothers with the same name.
C. Age and diagnosis: Age and diagnosis are important clinical information but are not typically used as primary identifiers for medication administration.
D. Footprints and identification number: While footprints and identification numbers may be used as supplemental identifiers, they are not as reliable or commonly used as name and medical record number for medication administration.

A. Insulin aspart: Insulin aspart is a rapid-acting insulin that can be mixed with certain types of insulin, such as NPH insulin, to provide both rapid and intermediate-acting coverage in a single injection.
B. Regular Insulin: Regular insulin is a short-acting insulin that can be mixed with intermediateacting insulins, such as NPH insulin, to provide both short and intermediate-acting coverage in a single injection.
C. Insulin glargine: Insulin glargine is a long-acting insulin that should not be mixed with other insulins due to its pH and precipitation properties.
D. Insulin detemir: Insulin detemir is a long-acting insulin that should not be mixed with other insulins due to its pH and precipitation properties.
E. Insulin lispro: Insulin lispro is a rapid-acting insulin that can be mixed with certain types of insulin, such as NPH insulin, to provide both rapid and intermediate-acting coverage in a single injection